ACAD Acadia Pharmaceuticals PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ACAD
- PE Ratio
The P/E ratio for Acadia Pharmaceuticals stock stands at 15.46 as of Jun 5, 2025. The calculation is based on the latest EPS of $1.38 and the stock price of $21.34 per share. A decrease of 54% has been observed in the PE ratio compared to its average of 33.9 of the past four quarters.
ACAD PE ratio history
Acadia Pharmaceuticals PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 13.39 | N/A | $18.35 | $1.37 |
| 2023 | N/A | N/A | $31.31 | -$0.37 |
| 2022 | N/A | N/A | $15.92 | -$1.34 |
| 2021 | N/A | N/A | $23.34 | -$1.05 |
| 2020 | N/A | N/A | $53.46 | -$1.79 |
| 2019 | N/A | N/A | $42.78 | -$1.6 |
| 2018 | N/A | N/A | $16.17 | -$1.94 |
| 2017 | N/A | N/A | $30.11 | -$2.36 |
| 2016 | N/A | N/A | $28.84 | -$2.34 |
| 2015 | N/A | N/A | $35.65 | -$1.63 |
| 2014 | N/A | N/A | $31.75 | -$0.95 |
| 2013 | N/A | N/A | $24.99 | -$0.44 |
| 2012 | N/A | N/A | $4.65 | -$0.38 |
| 2011 | N/A | N/A | $1.08 | -$0.44 |
| 2010 | 3.08 | N/A | $1.2 | $0.39 |
Acadia Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 12.04 | -10.08% | $16.61 | $1.38 |
| Dec 2024 | 13.39 | -32.1% | $18.35 | $1.37 |
| Sep 2024 | 19.72 | -78.16% | $15.38 | $0.78 |
| Jun 2024 | 90.28 | N/A | $16.25 | $0.18 |
| Mar 2024 | N/A | N/A | $18.49 | -$0.01 |
| Dec 2023 | N/A | N/A | $31.31 | -$0.37 |
| Sep 2023 | N/A | N/A | $20.84 | -$0.92 |
| Jun 2023 | N/A | N/A | $23.95 | -$0.69 |
| Mar 2023 | N/A | N/A | $18.82 | -$0.91 |
| Dec 2022 | N/A | N/A | $15.92 | -$1.34 |
| Sep 2022 | N/A | N/A | $16.36 | -$1.35 |
| Jun 2022 | N/A | N/A | $14.09 | -$1.27 |
| Mar 2022 | N/A | N/A | $24.22 | -$1.33 |
| Dec 2021 | N/A | N/A | $23.34 | -$1.05 |
| Sep 2021 | N/A | N/A | $16.61 | -$1.2 |
ACAD Price vs fair value
ACAD average PE ratio chart
ACAD PE vs peers
When compared to its peer stocks LLY and JNJ, ACAD's PE ratio is lower. Acadia Pharmaceuticals is currently trading at a lower PE ratio (15.46) than its peers average of 28.37.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ACAD Acadia Pharmaceuticals Inc | 15.96 | $3.69B |
| PFE Pfizer Inc | 16.89 | $133.49B |
| JNJ Johnson & Johnson | 17.14 | $373.64B |
| BMY Bristol Myers Squibb Co | 18.06 | $98.5B |
| LLY ELI LILLY & Co | 62.46 | $730.48B |
| VNDA Vanda Pharmaceuticals Inc | N/A | $258.72M |
Frequently asked questions
What is Acadia Pharmaceuticals's PE ratio?
The price to earnings ratio for ACAD stock as of Jun 5, 2025, stands at 15.46.
How is ACAD's PE ratio calculated (Acadia Pharmaceuticals PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 5, 2025), Acadia Pharmaceuticals's share price is $21.34. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.38. Therefore, Acadia Pharmaceuticals's price to earnings ratio for today is 15.46. PE RATIO(15.46) = STOCK PRICE($21.34) / TTM EPS($1.38)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.